ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,073,500 | -84.8% | 150,000 | -88.2% | 0.43% | -82.5% |
Q3 2022 | $20,204,000 | +16.0% | 1,265,900 | 0.0% | 2.48% | -6.2% |
Q2 2022 | $17,419,000 | -13.2% | 1,265,900 | 0.0% | 2.64% | -34.2% |
Q1 2022 | $20,077,000 | -63.7% | 1,265,900 | -50.0% | 4.02% | -63.9% |
Q4 2021 | $55,269,000 | -27.0% | 2,531,800 | 0.0% | 11.12% | -29.2% |
Q3 2021 | $75,676,000 | -32.5% | 2,531,800 | 0.0% | 15.71% | -29.6% |
Q2 2021 | $112,133,000 | -0.2% | 2,531,800 | 0.0% | 22.32% | -29.4% |
Q1 2021 | $112,336,000 | -30.9% | 2,531,800 | -14.6% | 31.61% | +27.3% |
Q4 2020 | $162,627,000 | +139.9% | 2,965,485 | 0.0% | 24.83% | +102.4% |
Q3 2020 | $67,791,000 | +9.2% | 2,965,485 | 0.0% | 12.27% | +103.3% |
Q2 2020 | $62,068,000 | +50.0% | 2,965,485 | 0.0% | 6.03% | +3.9% |
Q1 2020 | $41,369,000 | -38.7% | 2,965,485 | 0.0% | 5.81% | -28.0% |
Q4 2019 | $67,494,000 | +95.4% | 2,965,485 | 0.0% | 8.06% | +36.4% |
Q3 2019 | $34,548,000 | -22.3% | 2,965,485 | 0.0% | 5.91% | -1.7% |
Q2 2019 | $44,482,000 | -14.5% | 2,965,485 | 0.0% | 6.01% | -37.3% |
Q1 2019 | $52,015,000 | +18.4% | 2,965,485 | 0.0% | 9.58% | -4.9% |
Q4 2018 | $43,948,000 | -39.8% | 2,965,485 | 0.0% | 10.08% | -15.4% |
Q3 2018 | $73,010,000 | +25.4% | 2,965,485 | 0.0% | 11.92% | +61.6% |
Q2 2018 | $58,212,000 | +4.7% | 2,965,485 | 0.0% | 7.38% | -9.7% |
Q1 2018 | $55,603,000 | – | 2,965,485 | – | 8.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |